Technical Analysis for HELX - Franklin Genomic Advancements ETF

Grade Last Price % Change Price Change
D 40.78 -5.84% -2.53
HELX closed down 5.84 percent on Thursday, March 4, 2021, on 1.93 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical HELX trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction -5.84%
Below Lower BB Weakness -5.84%
Gapped Down Weakness -5.84%
Lower Bollinger Band Touch Weakness -5.84%
Oversold Stochastic Weakness -5.84%
Older End-of-Day Signals for HELX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 19 hours ago
Down 5% about 19 hours ago
Down 1 ATR about 22 hours ago
Down 3% about 22 hours ago
Down 2 % about 22 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovation
Classification

Keywords: Exchange Traded Fund ETF Biotechnology Life Sciences Biology Emerging Technologies Genetics Portfolio Management Molecular Biology Silicon Valley Quality Of Life DNA Personalized Medicine DNA Sequencing

Top 10 Components

Symbol Grade Price % Change Allocation
NTLA D -5.70 5.42
NTRA C -6.03 5.11
RGEN C -8.34 4.67
CRSP D -3.01 4.20
ILMN C -4.03 3.67
TDOC F -3.55 3.25
VEEV F -2.74 3.14
CTLT D -4.88 3.13
GH C -7.34 3.01
PACB D -7.06 2.38
View All HELX Holdings

Is HELX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 53.26
52 Week Low 18.41
Average Volume 6,192
200-Day Moving Average 37.78
50-Day Moving Average 47.79
20-Day Moving Average 48.88
10-Day Moving Average 46.74
Average True Range 1.81
ADX 33.05
+DI 17.13
-DI 52.64
Chandelier Exit (Long, 3 ATRs ) 47.82
Chandelier Exit (Short, 3 ATRs ) 46.09
Upper Bollinger Band 55.19
Lower Bollinger Band 42.57
Percent B (%b) -0.14
BandWidth 25.81
MACD Line -1.25
MACD Signal Line -0.09
MACD Histogram -1.161
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.31
Resistance 3 (R3) 44.65 43.83 43.72
Resistance 2 (R2) 43.83 42.93 43.65 43.52
Resistance 1 (R1) 42.30 42.37 41.89 41.96 43.33
Pivot Point 41.48 41.48 41.27 41.30 41.48
Support 1 (S1) 39.95 40.58 39.54 39.61 38.23
Support 2 (S2) 39.13 40.02 38.95 38.04
Support 3 (S3) 37.60 39.13 37.84
Support 4 (S4) 37.26